Escient Pharmaceuticals picks up Series B

San Diego-based Escient Pharmaceuticals Inc, a biotech firm, has secured $77.5 million in Series B financing.

14 September 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles